Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Diagnosis and Treatment of Neurological Diseases and Disorders
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -99.07% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 4 | 100.0 % | 0 | 100.0 % | -99.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Deborah Rathjen
CEO | Chief Executive Officer | - | 20/09/17 |
Dave Jenkins
DFI | Director of Finance/CFO | - | 30/06/21 |
Mei Mei Tian
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/11 |
Graeme Dick
IRC | Investor Relations Contact | - | 31/10/11 |
Christopher Lowe
SEC | Corporate Secretary | 56 | 02/10/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Hemeon
BRD | Director/Board Member | 59 | - |
David Wurzer
BRD | Director/Board Member | 65 | 26/07/18 |
Deborah Rathjen
CEO | Chief Executive Officer | - | 20/09/17 |
Director/Board Member | 63 | 31/05/18 | |
John E. Curran
BRD | Director/Board Member | - | 26/07/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 79,414,015 | 77,784,778 ( 97.95 %) | 0 | 97.95 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 290K | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- BTI Stock
- Company Bioasis Technologies Inc.